Epworth HealthCare is a provider of acute medical, surgical and rehabilitation services in Melbourne, Australia.

During the past decade, Epworth Hospital conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 4 clinical trials were completed, i.e. on average, 23.5% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Epworth Hospital" #1 sponsor was "Australian and New Zealand Intensive Care Research Centre" with 5 trials, followed by "Abbott Medical Devices" with 2 trials sponsored, "Canadian Cancer Trials Group" with 2 trials sponsored, "Dimerix Bioscience Pty Ltd" with 2 trials sponsored and "Astellas Pharma Global Development, Inc." with 2 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Epworth Hospital" #1 collaborator was "National Health and Medical Research Council, Australia" with 5 trials as a collaborator, "AstraZeneca" with 2 trials as a collaborator, "Iqvia Pty Ltd" with 2 trials as a collaborator, "ANZICS Clinical Trials Group" with 1 trials as a collaborator and "American College of Surgeons" with 1 trials as a collaborator. Other collaborators include 38 different institutions and companies that were collaborators in the rest 48 trials.

According to Clinical.Site data, the most researched conditions in "Epworth Hospital" are "Coronary Artery Disease" (2 trials), "Critically Ill" (2 trials), "Non-Small Cell Lung Cancer" (2 trials), "Acute Heart Failure" (1 trials) and "Acute Respiratory Failure" (1 trials). Many other conditions were trialed in "Epworth Hospital" in a lesser frequency.

Most popular intervention types in "Epworth Hospital" are "Drug" (13 trials), "Device" (4 trials), "Other" (4 trials), "Behavioral" (2 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Durvalumab" (2 trials), "Propagermanium" (2 trials), "0.9%NaCl" (1 trials) and "ASKP1240" (1 trials). Other intervention names were less common.

The vast majority of trials in "Epworth Hospital" are 22 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Epworth Hospital". undefined are not yet recruiting, 3 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Epworth Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Epworth Hospital, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".